Nicox Financial Statements From 2010 to 2025
| NICXFDelisted Stock | USD 0.44 0.00 0.00% |
Check Nicox SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nicox SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nicox financial statements analysis is a perfect complement when working with Nicox SA Valuation or Volatility modules.
Nicox |
Nicox SA Company Return On Equity Analysis
Nicox SA's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nicox SA Return On Equity | -0.65 |
Most of Nicox SA's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nicox SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Nicox SA has a Return On Equity of -0.6454. This is 97.31% lower than that of the Healthcare sector and 98.23% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 108.19% higher than that of the company.
Nicox SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nicox SA's current stock value. Our valuation model uses many indicators to compare Nicox SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nicox SA competition to find correlations between indicators driving Nicox SA's intrinsic value. More Info.Nicox SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nicox SA's earnings, one of the primary drivers of an investment's value.About Nicox SA Financial Statements
Nicox SA stakeholders use historical fundamental indicators, such as Nicox SA's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nicox SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nicox SA's assets and liabilities are reflected in the revenues and expenses on Nicox SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nicox SA. Please read more on our technical analysis and fundamental analysis pages.
Nicox S.A. operates as an ophthalmology company in France and internationally. The company was founded in 1996 and is headquartered in Valbonne, France. Nicox Sa operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 32 people.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Nicox Pink Sheet
If you are still planning to invest in Nicox SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nicox SA's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |